Allison N. DuRoss

Portland State University — United States

Engineering · Physical Sciences

11h-index613citations22works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Nanoplatforms for cancer theranostics(13), Nanoparticle-Based Drug Delivery(7), Metal-Organic Frameworks: Synthesis and Applications(7), Boron Compounds in Chemistry(5), Radiation Therapy and Dosimetry(4)

Publications22 total

Radiotherapy reimagined: Integrating nanomedicines into radiotherapy clinical trials
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology·2022· 9 cited
Preclinical data on co-delivery of temozolomide and talazoparib by fucodain-coated nanoscale metal organic frameworks for colorectal cancer chemoradiation
Data in Brief·2021· 5 citedOpen Access
Abstract PO-087: Novel high-throughput screen in a breast cancer cell line to identify potent radiosensitizers
Clinical Cancer Research·2021
Fucoidan-coated nanoparticles target radiation-induced P-selectin to enhance chemoradiotherapy in murine colorectal cancer
Cancer Letters·2020· 64 citedOpen Access
Low dose novel PARP-PI3K inhibition via nanoformulation improves colorectal cancer immunoradiotherapy
Materials Today Bio·2020· 24 citedOpen Access
Development of a Pemetrexed/Folic Acid Nanoformulation: Synthesis, Characterization, and Efficacy in a Murine Colorectal Cancer Model
ACS Omega·2020· 9 citedOpen Access
Metal-organic frameworks for radiation-based cancer therapies
2020
Metal-organic frameworks for radiation-based cancer therapies
2020
Metal-organic frameworks for radiation-based cancer therapies
2020
Metal-organic frameworks for radiation-based cancer therapies
2020
Metal-organic frameworks for radiation-based cancer therapies
2020
Formulation of Folate-Modified Raltitrexed-Loaded Nanoparticles for Colorectal Cancer Theranostics
Pharmaceutics·2020· 11 citedOpen Access
Co-delivery of PARP and PI3K inhibitors by nanoscale metal–organic frameworks for enhanced tumor chemoradiation
Nano Research·2019· 29 cited
PEGylated β-NaGdF<sub>4</sub>/Tb@CaF<sub>2</sub> Core/Shell Nanophosphors for Enhanced Radioluminescence and Folate Receptor Targeting
ACS Applied Nano Materials·2019· 16 cited
Integrating nanomedicine into clinical radiotherapy regimens
Advanced Drug Delivery Reviews·2019· 45 citedOpen Access
Micellar Formulation of Talazoparib and Buparlisib for Enhanced DNA Damage in Breast Cancer Chemoradiotherapy
ACS Applied Materials & Interfaces·2019· 22 citedOpen Access
Inverse-Micelle Synthesis of Doxorubicin-Loaded Alginate/Chitosan Nanoparticles and In Vitro Assessment of Breast Cancer Cytotoxicity
Colloids and Interface Science Communications·2018· 42 citedOpen Access
Nanoalginates via Inverse-Micelle Synthesis: Doxorubicin-Encapsulation and Breast Cancer Cytotoxicity
Nanoscale Research Letters·2018· 17 citedOpen Access
Biodistribution and Toxicity of Micellar Platinum Nanoparticles in Mice via Intravenous Administration
Nanomaterials·2018· 44 citedOpen Access
Radiolytic Nanoparticle Delivery of Radiation Sensitizers for BRCA-Proficient Triple Negative Breast Cancer
International Journal of Radiation Oncology*Biology*Physics·2017Open Access
page 1 of 2Next →

Frequent Co-authors

Conroy Sun(17), Madeleine Landry(14), Megan J. Neufeld(11), Gaurav Sahay(8), Hayden Winter(8), Justin G. Rosch(7), Charles R. Thomas(6), Guillem Pratx(6), Syamantak Khan(5), Prof. Andrea M. Goforth(5), Prof. Conroy Sun(5), Anna Brown(4), Siddharth Patel(2), N. Ashwanikumar(1), Emily Robinson(1), Kerry E. Murphy-Benenato(1), Cosmin Mihai(1), Örn Almarsson(1), Carl Ward(1), Anna St Lorenz(1)